Start here if you're new
what it is
Intel makes the chips inside PCs, servers, and networks, and it is trying to become a factory for other chip companies too.
how it gets paid
Last year Intel made $52.9B in revenue. Client Computing Group was the main engine at $29.2B, or 55% of sales.
why growth slowed
Revenue fell 0.5% last year on a ~$52.9B FY anchor. Ignore $39.2B / +187% vs. prior year style lines unless the filing proves the exact period—that pattern is usually a quarter (or non-revenue line) mislabeled as FY.
what just happened
Intel posted $0.15 EPS versus a $0.09 estimate, but the bigger story is still shaky profitability.
At a glance
B+ balance sheet — decent shape, but not bulletproof
30/100 earnings predictability — expect surprises
115.1x trailing p/e — you're paying up for this one
7.5% return on capital — nothing to write home about
xvary composite: 46/100 — below average
What they do
Intel makes the chips inside PCs, servers, and networks, and it is trying to become a factory for other chip companies too.
Intel still sits where a lot of computing starts: the CPU in your laptop and the server in a data center. About 76% of 2024 sales came from outside the U.S., which tells you this footprint is global, not local. The hard part for rivals is not just making a chip. It is replacing years of design tools, software support, and customer relationships once your machine already runs on Intel.
How they make money
$52.9B
annual revenue · their business grew -0.5% last year
Client Computing Group
$29.2B
Data Center and AI
$12.8B
Network and Edge
$5.8B
Mobileye
$1.7B
Foundry and other
$3.4B
The products that matter
designs and manufactures semiconductors
Semiconductor products and foundry
$52.9B revenue
this is the whole business in the data we have. the issue is not size. the health panel shows ~21.4% net margin while the KPI strip shows ~-4.2% operating margin—those do not describe one coherent GAAP year without one-offs or period mismatch; use Intel’s 10-K before trusting either headline.
the whole story
Key numbers
115.1x
trailing p/e
Jargon → trailing P/E → price divided by past profit → so what: the stock already prices in a comeback that has not shown up in margins.
-4.2%
operating margin (trailing · co.)
Negative at the operating line before interest and taxes—a bad look for a ~$192B name. The hero and this box should both read negative, not a silent positive.
$44.1B
long-term debt
That debt equals about 23% of the market cap, so Intel has less room for mistakes while funding fabs and R&D.
31.2%
r&d spend
Intel spends nearly one-third of sales on research, which tells you this turnaround is expensive before it is profitable.
Financial health
B+
strength
- balance sheet grade B+ — solid but not elite
- risk rank 3 — safer than 50% of stocks
- price stability 25 / 100
- long-term debt $44.1B (19% of capital)
- net profit margin 21.4% — keeps 21 cents of every dollar in revenue
- return on equity 10% — $0.10 profit for every $1 investors have put in
B+ — functional but not a standout on the balance sheet.
Total return vs. market
You invested $10,000 in INTC 3 years ago → it's now worth $14,700.
The index would have given you $13,920.
source: institutional data · total return
What just happened
beat estimates
Intel posted $0.15 EPS versus a $0.09 estimate, but the bigger story is still shaky profitability.
Use ~$14.3B as the quarterly revenue scale in this row versus ~$52.9B FY in the table—do not paste a $39.2B “revenue” line here without the same period label. EPS can read $0.15 on one definition and ~$0.07 on another (GAAP vs adjusted); match the vendor before comparing.
$14.3B
revenue (Q)
$0.15
eps (Q · as in hero)
34.3%
gross margin (Q)
the number that mattered
34.3% gross margin matters most because it shows how much money is left after making the chips, and that cushion is thin for a company funding a factory rebuild.
-
intel shares have bounced back sharply in 2025.
-
at the time of this writing, the stock has more than doubled in price thus far in 2025.
-
there are a few key variables that are helping to support the share price.
-
for one, a $5 billion investment from industry heavyweight nvidia has provided a significant shot in the arm, what’s more, the u.s. government invested in the beleaguered former industry leader and now has a 10% equity interest via the chips act grant.the capital support from nvidia and the government has helped to boost its overall financial position and restored some confidence with investors.
-
there has also been some optimism regarding its foundry operations, which have been struggling.there are also expectations that the company can make a more-significant splash in the lucrative ai realm, thanks, at least in part, to its relationship with nvidia.
source: company earnings report, 2026
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
intel's risk stack is specific, not generic: the company is trying to fund a foundry comeback while earning only $0.35 per share and keeping just 5.2% of revenue as net profit.
med
foundry buildout has to become a business, not just a strategy slide
Intel is spending heavily to compete with TSMC and Samsung in contract manufacturing. With full-year EPS at just $0.35, delays or weak outside demand matter fast.
if foundry traction slips, you are left paying 115.1x trailing earnings for a company that still looks unfinished on paper.
med
competition is pressuring multiple parts of the business at once
AMD, Nvidia, and Arm are not waiting around. Pressure across pcs, servers, and AI-adjacent markets already shows up in a 5.2% net margin on $52.9B in revenue.
if share losses continue, revenue can stay big while profit stays small. that is a bad setup for a stock already priced for better days.
med
the valuation leaves little room for another earnings wobble
INTC trades at 115.1x trailing earnings and earns a 2.0% return on capital. That gap is the key tension on the page.
if FY2026 EPS stays near $0.65 instead of moving higher, investors may decide the rebound got ahead of the business.
med
capital support buys time, not automatic proof
The $5B Nvidia investment and chips act support help the funding story, but they do not fix a 30/100 earnings predictability score or the uneven quarterly EPS path.
if better funding is not followed by better margins and steadier earnings, the market may stop giving Intel the benefit of the doubt.
at $40.30, you are paying 115.1x trailing earnings for a business that earned $0.35 per share last year and kept 5.2% of revenue as profit. that leaves very little room for turnaround delays.
source: institutional data · regulatory filings · risk analysis
Pay attention to
risk
foundry customer traction
the whole rerating story needs real outside demand for Intel manufacturing. optimism does not pay for fabs.
metric
the gap between $0.35 actual EPS and $0.65 estimated EPS
that gap is the turnaround in one line. if estimates fall instead of rise, the multiple gets harder to defend.
trend
margin recovery
16.0% operating margin and 5.2% net margin are better than crisis numbers, not good numbers. the next step has to be higher.
calendar
the next earnings print after the 2025 rally
after a move from $18 to $44 inside the 52-week range, each quarter now has to prove the rebound belongs to the business, not just the chart.
Analyst rankings
short-term outlook
below average
momentum score 4 — analysts see underperformance risk from here. in human-speak, they think the easy bounce may be behind you.
risk profile
average
stability score 3 — middle of the pack. not a bunker stock, not a disaster either.
chart momentum
top 20%
technical score 2 — the chart still looks strong even though the earnings picture is still messy.
earnings predictability
30 / 100
earnings can surprise in both directions. if you own this, you own a stock where forecasts deserve skepticism.
source: institutional data
Institutional activity
institutions have been net selling for 3 consecutive quarters — 1,015 buyers vs. 1,046 sellers in 3q2025. net selling for 3 quarters.
source: institutional data
Price targets
3-5 year target range
$13
$54
$40
current price
$34
target midpoint · 16% from current · 3-5yr high: $75 (+85% · 17% ann'l return)
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive